Prelude Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,758
| Closed | -$8K | – | 1968 |
|
|
2018
Q4 | $8K | Buy |
+2,758
| New | +$8K | ﹤0.01% | 1089 |
|
|
2017
Q4 | – | Sell |
-67,233
| Closed | -$228K | – | 1838 |
|
|
2017
Q3 | $228K | Buy |
67,233
+39,933
| +146% | +$135K | 0.02% | 546 |
|
|
2017
Q2 | $67K | Sell |
27,300
-79,800
| -75% | -$196K | 0.01% | 818 |
|
|
2017
Q1 | $243K | Buy |
107,100
+33,900
| +46% | +$76.9K | 0.02% | 459 |
|
|
2016
Q4 | $155K | Buy |
73,200
+34,071
| +87% | +$72.1K | 0.02% | 637 |
|
|
2016
Q3 | $131K | Buy |
39,129
+9,329
| +31% | +$31.2K | 0.01% | 673 |
|
|
2016
Q2 | $94K | Buy |
+29,800
| New | +$94K | 0.01% | 747 |
|
|
2015
Q4 | – | Sell |
-34,458
| Closed | -$173K | – | 1849 |
|
|
2015
Q3 | $173K | Buy |
+34,458
| New | +$173K | 0.03% | 597 |
|
|
2015
Q2 | – | Sell |
-4,500
| Closed | -$32K | – | 2267 |
|
|
2015
Q1 | $32K | Hold |
4,500
| – | – | ﹤0.01% | 1590 |
|
|
2014
Q4 | $35K | Buy |
+4,500
| New | +$35K | 0.01% | 1464 |
|
|
2014
Q3 | – | Sell |
-13,800
| Closed | -$134K | – | 2256 |
|
|
2014
Q2 | $134K | Buy |
13,800
+7,000
| +103% | +$68K | 0.02% | 834 |
|
|
2014
Q1 | $57K | Sell |
6,800
-2,520
| -27% | -$21.1K | 0.01% | 1111 |
|
|
2013
Q4 | $79K | Buy |
9,320
+5,120
| +122% | +$43.4K | 0.01% | 867 |
|
|
2013
Q3 | $33K | Buy |
+4,200
| New | +$33K | 0.01% | 972 |
|